Pharmabiz13h
Daiichi Sankyo appoints Hiroyuki Okuzawa as chief executive officer
Daiichi Sankyo appoints Hiroyuki Okuzawa as chief executive officer: Tokyo Saturday, February 1, 2025, 12:30 Hrs [IST] ...
Pharmabiz10h
Celltrion’s Avtozma, a biosimilar to Actemra receives US FDA approval to treat RA, GCA, pJIA, sJIA and Covid-19
Jersey City, New Jersey Saturday, February 1, 2025, 16:00 Hrs [IST] ...
Pharmabiz12h
Vertex Pharmaceuticals’ suzetrigine gets US FDA approval for treatment of adults with moderate-to-severe acute pain
Vertex Pharmaceuticals’ suzetrigine gets US FDA approval for treatment of adults with moderate-to-severe acute pain: Boston Saturday, February 1, 2025, 14:00 Hrs [IST] Vertex Ph ...
Pharmabiz8h
Onco-Innovations’ licensed technology demonstrates promise to enhance chemotherapy effectiveness by overcoming cancer cell resistance
Onco-Innovations’ licensed technology demonstrates promise to enhance chemotherapy effectiveness by overcoming cancer cell resistance: Vancouver, BC Saturday, February 1, 2025, ...
Pharmabiz11h
Angle announces new results for dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platform
Angle announces new results for dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platform: London Saturday, February 1, 2025, 15:00 Hrs [IST] Angle plc, a wo ...
Pharmabiz13h
Enveric Biosciences receives notice of allowance from USPTO for its drug candidate EB-003 to treat mental health disorders
Enveric Biosciences receives notice of allowance from USPTO for its drug candidate EB-003 to treat mental health disorders: Cambridge, Massachusetts Saturday, February 1, 2025, 13 ...
Pharmabiz9h
Indian pharma gives thumbs up to Budget’s Manufacturing Mission & classification of MSME criteria
Indian pharma gives thumbs up to Budget’s Manufacturing Mission & classification of MSME criteria: Our Bureau, Bengaluru Saturday, February 1, 2025, 16:45 Hrs [IST] India pharma ...
Pharmabiz8h
Union budget 2025 defeats the objective of Make in India programme: KDPMA
Union budget 2025 defeats the objective of Make in India programme: KDPMA: Nandita Vijayasimha, Bengaluru Saturday, February 1, 2025, 17:20 Hrs [IST] The Karnataka Drugs and Pharm ...
Pharmabiz10h
Budget 2025 proposes to transform cancer care, medical education, and global healthcare leadership: Experts
Budget 2025 proposes to transform cancer care, medical education, and global healthcare leadership: Experts: Our Bureau, Mumbai Saturday, February 1, 2025, 15:40 Hrs [IST] The Uni ...
Pharmabiz9h
Telix Pharma completes acquisition of next-generation therapeutic assets & innovative biologics technology platform of ImaginAb
Telix Pharma completes acquisition of next-generation therapeutic assets & innovative biologics technology platform of ImaginAb: Melbourne, Australia Saturday, February 1, 2025, 1 ...
Pharmabiz10h
Karnataka healthcare upbeat on Budget with exemption of BCDs and addition of medical seats
Karnataka healthcare upbeat on Budget with exemption of BCDs and addition of medical seats: Our Bureau, Bengaluru Saturday, February 1, 2025, 15:25 Hrs [IST] The healthcare sector ...
Pharmabiz9h
Health budget witnesses 9.7% growth, experts laud decisions related to healthcare
Health budget witnesses 9.7% growth, experts laud decisions related to healthcare: Our Bureau, New Delhi Saturday, February 1, 2025, 17:05 Hrs [IST] The Union Budget 2025 has prop ...